2023-04-14Zeitschriftenartikel
Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
| dc.contributor.author | Stoliaroff-Pepin, Anna | |
| dc.contributor.author | Harder, Thomas | |
| dc.date.accessioned | 2026-01-19T12:31:14Z | |
| dc.date.available | 2026-01-19T12:31:14Z | |
| dc.date.issued | 2023-04-14 | none |
| dc.identifier.other | 10.1016/S1473-3099(23)00187-1 | |
| dc.identifier.uri | http://edoc.rki.de/176904/13166 | |
| dc.language.iso | eng | none |
| dc.publisher | Robert Koch-Institut | |
| dc.rights | (CC BY 3.0 DE) Namensnennung 3.0 Deutschland | ger |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/de/ | |
| dc.subject | COVID-19 Vaccines | eng |
| dc.subject | COVID-19* / prevention & control | eng |
| dc.subject | Humans | eng |
| dc.subject | Public Health | eng |
| dc.subject.ddc | 610 Medizin und Gesundheit | none |
| dc.title | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations | none |
| dc.type | article | |
| dc.identifier.urn | urn:nbn:de:0257-176904/13166-8 | |
| dc.type.version | publishedVersion | none |
| local.edoc.container-title | The Lancet Infectious Diseases | none |
| local.edoc.type-name | Zeitschriftenartikel | |
| local.edoc.container-type | periodical | |
| local.edoc.container-type-name | Zeitschrift | |
| local.edoc.container-publisher-name | Elsevier B.V. | none |
| local.edoc.container-reportyear | 2023 | none |
| local.edoc.container-firstpage | 881 | none |
| local.edoc.container-lastpage | 882 | none |
| dc.description.version | Peer Reviewed | none |